HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao Zhang Selected Research

Doxorubicin (Adriamycin)

1/2022Synthesis of novel dual target inhibitors of PARP and EGFR and their antitumor activities in triple negative breast cancers.
12/2021Hyaluronate-Based Self-Stabilized Nanoparticles for Immunosuppression Reversion and Immunochemotherapy in Osteosarcoma Treatment.
1/2020Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer.
9/2018Engineering Anticancer Amphipathic Peptide-Dendronized Compounds for Highly-Efficient Plasma/Organelle Membrane Perturbation and Multidrug Resistance Reversal.
1/2018Intelligent MoS2 Nanotheranostic for Targeted and Enzyme-/pH-/NIR-Responsive Drug Delivery To Overcome Cancer Chemotherapy Resistance Guided by PET Imaging.
11/2017Bioreducible Peptide-Dendrimeric Nanogels with Abundant Expanded Voids for Efficient Drug Entrapment and Delivery.
1/2016Mesoporous Bamboo Charcoal Nanoparticles as a New Near-Infrared Responsive Drug Carrier for Imaging-Guided Chemotherapy/Photothermal Synergistic Therapy of Tumor.
9/2015Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells.
6/2014One-pot template-free synthesis of NaYF4 upconversion hollow nanospheres for bioimaging and drug delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao Zhang Research Topics

Disease

234Neoplasms (Cancer)
10/2022 - 01/2007
52Inflammation (Inflammations)
06/2022 - 05/2005
37Neoplasm Metastasis (Metastasis)
10/2022 - 12/2007
35Breast Neoplasms (Breast Cancer)
01/2022 - 01/2007
31Infections
12/2022 - 03/2010
31Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2010
28Carcinogenesis
02/2022 - 01/2007
23Stroke (Strokes)
07/2022 - 02/2011
20Liver Neoplasms (Liver Cancer)
07/2022 - 12/2014
20Alzheimer Disease (Alzheimer's Disease)
03/2022 - 04/2004
19Ischemic Stroke
07/2022 - 10/2012
17Pain (Aches)
01/2021 - 01/2002
15Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 11/2012
15Lung Neoplasms (Lung Cancer)
01/2022 - 08/2011
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2012
12Insulin Resistance
09/2022 - 01/2012
12Rheumatoid Arthritis
01/2021 - 01/2002
11Adenocarcinoma of Lung
02/2022 - 04/2015
11Hemorrhage
01/2022 - 08/2013
10Epstein-Barr Virus Infections
11/2022 - 01/2018
10COVID-19
09/2022 - 01/2020
10Prostatic Neoplasms (Prostate Cancer)
07/2022 - 11/2012
10Neuroinflammatory Diseases
03/2022 - 10/2012
10Fibrosis (Cirrhosis)
01/2022 - 01/2015
10Triple Negative Breast Neoplasms
01/2022 - 01/2015
10Ischemia
12/2020 - 02/2011
9Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 02/2017
9Hypoxia (Hypoxemia)
01/2022 - 01/2015
9Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2005
8Melanoma (Melanoma, Malignant)
10/2022 - 05/2010
8Parkinson Disease (Parkinson's Disease)
06/2022 - 01/2015
8Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 10/2014
8Obesity
01/2022 - 01/2011
8Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 05/2012
8Hypertension (High Blood Pressure)
01/2022 - 05/2009
8Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 02/2010
8Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 11/2012
8Hyperalgesia
01/2022 - 03/2012
8Stomach Neoplasms (Stomach Cancer)
07/2021 - 04/2007
8Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 04/2012
7Alcoholism (Alcohol Abuse)
09/2022 - 01/2013
7Osteoporosis
05/2022 - 05/2008
7Interstitial Lung Diseases (Interstitial Lung Disease)
05/2022 - 10/2008
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2022 - 11/2011
7Starvation
01/2022 - 06/2009
7Body Weight (Weight, Body)
03/2020 - 01/2011
7Brain Ischemia (Cerebral Ischemia)
01/2020 - 01/2012
7Hepatitis E
01/2019 - 12/2005
6Disease Resistance
01/2022 - 04/2017

Drug/Important Bio-Agent (IBA)

73Proteins (Proteins, Gene)FDA Link
02/2022 - 04/2004
52Pharmaceutical PreparationsIBA
05/2022 - 11/2009
44Biomarkers (Surrogate Marker)IBA
09/2022 - 08/2011
30MicroRNAs (MicroRNA)IBA
01/2022 - 05/2010
23VaccinesIBA
11/2022 - 05/2014
19Biological ProductsIBA
07/2022 - 07/2013
18Long Noncoding RNAIBA
06/2022 - 12/2014
18Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2011
18Messenger RNA (mRNA)IBA
02/2022 - 01/2007
18Therapeutic UsesIBA
01/2022 - 10/2012
17DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2011
16EnzymesIBA
01/2022 - 01/2009
15heparanaseIBA
01/2022 - 05/2005
14LipidsIBA
09/2022 - 01/2013
14Retinaldehyde (Retinal)IBA
01/2022 - 09/2008
13Small Interfering RNA (siRNA)IBA
11/2020 - 01/2007
12Transcription Factors (Transcription Factor)IBA
09/2022 - 03/2010
12Amyloid (Amyloid Fibrils)IBA
03/2022 - 04/2004
12CytokinesIBA
12/2021 - 03/2010
12C-Reactive ProteinIBA
11/2021 - 11/2013
12AntigensIBA
03/2021 - 03/2010
12Peptides (Polypeptides)IBA
03/2020 - 11/2009
11AntibodiesIBA
12/2022 - 02/2012
11AntioxidantsIBA
03/2022 - 02/2011
10Immunoglobulin G (IgG)IBA
12/2022 - 11/2009
10InterferonsIBA
01/2022 - 08/2013
10Heparitin Sulfate (Heparan Sulfate)IBA
02/2015 - 05/2005
9Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 06/2014
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2020 - 01/2007
9ErbB Receptors (EGF Receptor)IBA
01/2019 - 10/2011
8Reactive Oxygen Species (Oxygen Radicals)IBA
08/2022 - 07/2017
8Circular RNAIBA
07/2022 - 01/2018
8RNA (Ribonucleic Acid)IBA
05/2022 - 12/2005
8Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 06/2004
8CreatinineIBA
11/2018 - 02/2011
7CateninsIBA
05/2022 - 10/2014
7Particulate MatterIBA
04/2022 - 11/2012
7AnticoagulantsIBA
01/2021 - 10/2016
7ginsenoside RdIBA
01/2020 - 02/2011
6Interleukin-6 (Interleukin 6)IBA
05/2022 - 11/2013
6Monoclonal AntibodiesIBA
04/2022 - 08/2013
6Immune Checkpoint InhibitorsIBA
03/2022 - 11/2020
6salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2007

Therapy/Procedure

120Therapeutics
10/2022 - 07/2009
31Drug Therapy (Chemotherapy)
07/2022 - 09/2012
19Immunotherapy
05/2022 - 11/2009
13Radiotherapy
04/2022 - 10/2013
13Photothermal Therapy
04/2020 - 07/2014
11Precision Medicine
01/2021 - 07/2014
8Aftercare (After-Treatment)
03/2021 - 09/2006
6Length of Stay
01/2022 - 07/2012